What is Allylix?
Allylix operates as a specialized entity within the biotechnology sector, focusing on the development of advanced solutions that bridge the gap between scientific research and commercial application. The company is recognized for its expertise in creating high-value ingredients and sustainable processes, often leveraging proprietary platforms to address unmet needs in the food, beverage, and industrial markets. By maintaining a strong intellectual property portfolio and a clear focus on defensible technology, Allylix has established a robust market position that appeals to both venture capital firms and strategic corporate investors.
The firm's operational model is characterized by a rigorous approach to product commercialization, prioritizing scalability and long-term viability. This strategic focus has allowed the company to maintain a competitive edge, ensuring that its innovations are not only scientifically sound but also economically advantageous for its partners and clients.
How much funding has Allylix raised?
Allylix has raised a total of $34.5M across 5 funding rounds:
Series A
$1.5M
Series B
$3.4M
Series C
$9M
Unspecified
$18.2M
Debt
$2.5M
Series A (2005): $1.5M with participation from Bluegrass Angels, Carolyn Fritz, Kentucky Science and Technology Corporation (KSTC), and Commonwealth Seed Capital
Series B (2007): $3.4M led by Tech Coast Angels and Life Science Angels
Series C (2010): $9M supported by Blue Grass Angels, Life Science Angels, Tech Coast Angels, Tate & Lyle Ventures, and Pasadena Angels
Unspecified (2012): $18.2M featuring Avrio Ventures, Tate & Lyle Ventures, and Cultivian Ventures
Debt (2014): $2.5M backed by Soffinova Ventures, Circadia Ventures LLP, and Cultivian Ventures
Key Investors in Allylix
Soffinova Ventures
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability, providing hands-on support from seed to later-stage investments.
Circadia Ventures LLP
Circadia Ventures focuses on equity investments in the food sector, targeting companies with strong, defensible technology platforms and the ambition to build high-growth businesses.
Cultivian Ventures
Cultivian Ventures selects best-of-breed investment opportunities, prioritizing experienced management teams and unique, proprietary products with significant competitive advantages.
What's next for Allylix?
Looking ahead, the recent capital injection is expected to catalyze the next phase of Allylix's growth, likely focusing on the expansion of its commercial footprint and the optimization of its production capabilities. With a history of attracting sophisticated investors, the company is well-positioned to leverage its current financial standing to explore new market segments or enhance its existing product pipeline. The strategic alignment with its current investor base suggests a continued emphasis on achieving significant milestones that will drive value for stakeholders and solidify the company's leadership in the biotechnology space.
See full Allylix company page
